4.8 Article

Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells

Related references

Note: Only part of the references are listed.
Review Oncology

Phospholipase D Meets Wnt Signaling: A New Target for Cancer Therapy

Dong Woo Kang et al.

CANCER RESEARCH (2011)

Article Multidisciplinary Sciences

Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host

Ludovico Buti et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Biochemistry & Molecular Biology

Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells

Dong Woo Kang et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2010)

Article Gastroenterology & Hepatology

Regulation of p53 Tumor Suppressor by Helicobacter pylori in Gastric Epithelial Cells

Jinxiong Wei et al.

GASTROENTEROLOGY (2010)

Review Oncology

Helicobacter pylori: gastric cancer and beyond

D. Brent Polk et al.

NATURE REVIEWS CANCER (2010)

Article Biochemistry & Molecular Biology

Helicobacter pylori CagA activates NF-κB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination

Acacia Lamb et al.

EMBO REPORTS (2009)

Article Multidisciplinary Sciences

Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse

Naomi Ohnishi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Pharmacology & Pharmacy

The potential for phospholipase D as a new therapeutic target

Ping Huang et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2007)

Article Biochemistry & Molecular Biology

Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner

Maria J. Oliveira et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Review Gastroenterology & Hepatology

15th anniversary of rebamipide: Looking ahead to the new mechanisms and new applications

T Arakawa et al.

DIGESTIVE DISEASES AND SCIENCES (2005)

Article Biochemistry & Molecular Biology

Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B

A Tarnawski et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)

Article Multidisciplinary Sciences

NF-κB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein

S Brandt et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Oncology

Oncogenic mechanisms of the Helicobacter pylori CagA protein

M Hatakeyama

NATURE REVIEWS CANCER (2004)

Article Gastroenterology & Hepatology

Meta-analysis of the relationship between cagA seropositivity and gastric cancer

JQ Huang et al.

GASTROENTEROLOGY (2003)

Article Gastroenterology & Hepatology

Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor κB

N Mori et al.

GASTROENTEROLOGY (2003)

Article Biochemistry & Molecular Biology

Grb2 is a key mediator of Helicobacter pylori CagA protein activities

H Mimuro et al.

MOLECULAR CELL (2002)

Article Biochemistry & Molecular Biology

Changes of interleukin expression correlate with Helicobacter pylori infection and lymph node metastases in gastric carcinoma

XY Zhang et al.

DIAGNOSTIC MOLECULAR PATHOLOGY (2002)

Review Oncology

Helicobacter pylori and gastrointestinal tract adenocarcinomas

RM Peek et al.

NATURE REVIEWS CANCER (2002)

Article Gastroenterology & Hepatology

Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats

S Kishimoto et al.

DIGESTIVE DISEASES AND SCIENCES (2000)